ArticleJournal of the National Cancer Institute2024

Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor Study.

Danielle Novetsky Friedman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.